Degen O - Search Results

1

Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy.

Albrecht H, Hoffmann C, Degen O, Stoehr A, Plettenberg A, Mertenskötter T, Eggers C, Stellbrink HJ. Albrecht H, et al. Among authors: degen o. AIDS. 1998 Jul 9;12(10):1149-54. doi: 10.1097/00002030-199810000-00006. AIDS. 1998. PMID: 9677163

2

Clinical significance of qualitative human cytomegalovirus (HCMV) detection in cell-free serum samples in HIV-infected patients at risk for HCMV disease.

Laue T, Mertenskötter T, Grewing T, Degen O, van Lunzen J, Dietrich M, Schmitz H. Laue T, et al. Among authors: degen o. AIDS. 1997 Jul 15;11(9):1195-6. doi: 10.1097/00002030-199709000-00023. AIDS. 1997. PMID: 9233475 No abstract available.

3

Highly active antiretroviral therapy leads to a significant but delayed increase of CD45RA+ T-helper cells.

Degen O, Stellbrink HJ, Lauer J, van Lunzen J. Degen O, et al. AIDS. 1998 Sep 10;12(13):1715-6. AIDS. 1998. PMID: 9764793 No abstract available.

4

Intensification of background antiretroviral therapy with abacavir during low-level failure may restore optimal suppression.

Degen O, van Lunzen J, Stellbrink HJ. Degen O, et al. Antivir Ther. 2000 Jun;5(2):91-4. Antivir Ther. 2000. PMID: 10971861

5

HHV-8 DNA in blood and the development of HIV-associated Kaposi's sarcoma in the era of HAART--a prospective evaluation.

Lorenzen T, Albrecht D, Paech V, Meyer T, Hoffmann C, Stoehr A, Degen O, Stellbrink HJ, Meigel WN, Arndt R, Plettenberg A. Lorenzen T, et al. Among authors: degen o. Eur J Med Res. 2002 Jun 28;7(6):283-6. Eur J Med Res. 2002. PMID: 12117665 Clinical Trial.

6

Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial).

Stellbrink HJ, van Lunzen J, Westby M, O'Sullivan E, Schneider C, Adam A, Weitner L, Kuhlmann B, Hoffmann C, Fenske S, Aries PS, Degen O, Eggers C, Petersen H, Haag F, Horst HA, Dalhoff K, Möcklinghoff C, Cammack N, Tenner-Racz K, Racz P. Stellbrink HJ, et al. Among authors: o sullivan e, degen o. AIDS. 2002 Jul 26;16(11):1479-87. doi: 10.1097/00002030-200207260-00004. AIDS. 2002. PMID: 12131185 Clinical Trial.

7

Pneumocystis carinii pneumonia after the discontinuation of secondary prophylaxis.

Degen O, ven Lunzen J, Horstkotte MA, Sobottka I, Stellbrink HJ. Degen O, et al. AIDS. 2002 Jul 5;16(10):1433-4. doi: 10.1097/00002030-200207050-00021. AIDS. 2002. PMID: 12131226 No abstract available.

8

Adoptive transfer of syngeneic T cells in HIV-1 discordant twins indicates rapid regulation of T-cell homeostasis.

Hoffmann C, Stellbrink HJ, Dielschneider T, Degen O, Stoehr A, Knechten H, Wolf E, van Lunzen J. Hoffmann C, et al. Among authors: degen o. Br J Haematol. 2007 Feb;136(4):641-8. doi: 10.1111/j.1365-2141.2006.06478.x. Br J Haematol. 2007. PMID: 17223918 Free article.

9

Loss to follow-up in an international, multicentre observational study.

Mocroft A, Kirk O, Aldins P, Chies A, Blaxhult A, Chentsova N, Vetter N, Dabis F, Gatell J, Lundgren JD; EuroSIDA study group. Mocroft A, et al. HIV Med. 2008 May;9(5):261-9. doi: 10.1111/j.1468-1293.2008.00557.x. HIV Med. 2008. PMID: 18400074 Free article.

10

Transmitted drug resistant HIV-1 and association with virologic and CD4 cell count response to combination antiretroviral therapy in the EuroSIDA Study.

Bannister WP, Cozzi-Lepri A, Clotet B, Mocroft A, Kjaer J, Reiss P, von Wyl V, Lazzarin A, Katlama C, Phillips AN, Ruiz L, Lundgren JD; EuroSIDA study group. Bannister WP, et al. J Acquir Immune Defic Syndr. 2008 Jul 1;48(3):324-33. doi: 10.1097/QAI.0b013e31817ae5c0. J Acquir Immune Defic Syndr. 2008. PMID: 18545152 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

134 results

Search Page